Asset Details
Do you wish to reserve the book?
Inflammation and Premature Ageing in Chronic Kidney Disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inflammation and Premature Ageing in Chronic Kidney Disease
Do you wish to request the book?
Inflammation and Premature Ageing in Chronic Kidney Disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Inflammation and Premature Ageing in Chronic Kidney Disease
2020
Overview
Persistent low-grade inflammation and premature ageing are hallmarks of the uremic phenotype and contribute to impaired health status, reduced quality of life, and premature mortality in chronic kidney disease (CKD). Because there is a huge global burden of disease due to CKD, treatment strategies targeting inflammation and premature ageing in CKD are of particular interest. Several distinct features of the uremic phenotype may represent potential treatment options to attenuate the risk of progression and poor outcome in CKD. The nuclear factor erythroid 2-related factor 2 (NRF2)–kelch-like erythroid cell-derived protein with CNC homology [ECH]-associated protein 1 (KEAP1) signaling pathway, the endocrine phosphate-fibroblast growth factor-23–klotho axis, increased cellular senescence, and impaired mitochondrial biogenesis are currently the most promising candidates, and different pharmaceutical compounds are already under evaluation. If studies in humans show beneficial effects, carefully phenotyped patients with CKD can benefit from them.
Publisher
MDPI AG,MDPI
Subject
/ ageing
/ Aging
/ Aging, Premature - metabolism
/ Aging, Premature - mortality
/ Aging, Premature - physiopathology
/ Animals
/ Homology
/ Humans
/ Inflammation - physiopathology
/ Inflammation Mediators - metabolism
/ Kidneys
/ Kinases
/ Proteins
/ Renal Insufficiency, Chronic - metabolism
/ Renal Insufficiency, Chronic - mortality
/ Renal Insufficiency, Chronic - physiopathology
/ Renal Insufficiency, Chronic - therapy
/ Review
